Amigo AI has secured $11 million in Series A funding to grow its platform that trains AI agents to interact directly with patients. This new round was led by Madrona, with participation from Optum Ventures. Including an earlier seed round co-led by General Catalyst and GSV Ventures, the company has now raised $17 million in total funding. The investment comes at a time when healthcare providers are increasingly seeking technology solutions to handle rising patient demand and staff shortages.

Expanding Clinical AI Capabilities

The fresh funding will help Amigo AI broaden its platform and advance the development of its clinical agent training system. The company aims to make its software accessible to more healthcare providers and a variety of use cases. Their platform enables automation of tasks like patient intake, triage, and ongoing support, freeing up medical staff for more complex care. This approach is designed to support healthcare organizations that want to introduce automation without compromising safety or quality standards.

Amigo’s AI agents are built to interact directly with patients while operating under strict safety controls. This focus on safety and trust is critical, especially in healthcare settings where mistakes can have serious consequences. The platform’s simulation-first approach is intended to set a high standard for patient-facing AI, ensuring it functions reliably in real-world scenarios.

Addressing Healthcare Workforce Challenges

Healthcare systems worldwide face a widening workforce gap. By 2030, projections suggest there could be a shortage of over 11 million healthcare professionals globally. Digital clinical agents are seen as one way to help bridge this gap by assisting medical teams with routine interactions and administrative tasks. These AI systems can handle structured conversations with patients, which helps healthcare providers maintain quality of care even as demand grows.

At the same time, healthcare requires very high levels of reliability. Trust and safety are non-negotiable, and Amigo AI’s focus on rigorous simulation and safety protocols aims to meet these strict standards. As Sabrina Albert, a partner at Madrona, notes, Amigo AI is tackling one of the most challenging problems in healthcare AI by deploying autonomous systems with safety at their core.

The company plans to use the new capital to enhance its simulation systems further and improve the models that train its clinical agents. This will allow the AI to better handle a wider range of real patient interactions, making the technology more versatile and reliable. By automating routine workflows, Amigo AI hopes to help medical teams focus their time and expertise on complex cases that truly require human judgment.

Inspired by

• https://justainews.com/companies/funding-news/amigo-ai-secures-11m-series-a-for-healthcare-ai/